Visa – Stock Analysis

In this Visa stock analysis I: disclose my July 12th purchase of 100 additional Visa shares; and provide an update on the status of the $250 July 16 2021 covered call option contracts I disclosed in my May 26th Visa - Options Trade Review post. V is our largest holding (FFJ Portfolio Holdings Review: April [...]

By |July 11th, 2021|Equity Investing, Options|Comments Off on Visa – Stock Analysis

RBC and TD – Dividend Boost and Share Repurchases on the Horizon

I recently analyzed The Canadian Imperial Bank of Commerce (CM) and have written a guest post for Dividend Power about The Bank of Montreal (BMO) which should be posted within the next couple of weeks. I will not increase my position in either bank based on my analyses. Like CM and BMO, The Royal Bank [...]

By |July 5th, 2021|Equity Investing|Comments Off on RBC and TD – Dividend Boost and Share Repurchases on the Horizon

Bristol-Myers Squibb – Stock Analysis

The irrational exuberance we are currently witnessing has led to a significant reduction in the number of attractively valued high-quality companies. Despite this challenge, however, there are some companies with the potential to generate an attractive total return. This Bristol-Myers Squibb stock analysis explains why BMY is one such company. Despite its attractiveness, I do [...]

By |July 2nd, 2021|Equity Investing|Comments Off on Bristol-Myers Squibb – Stock Analysis

FFJ Portfolio – June 2021 Report

This is my FFJ Portfolio - June 2021 Report. During the month I initiated positions in Rollins (500 shares) and Viatris (400 shares). I also added 200 Vontier shares and 100 Heico shares to increase my exposure to these companies. Details about these purchases are found in articles within the FFJ Archives. In addition to [...]

By |July 1st, 2021|FFJ Portfolio Holdings|Comments Off on FFJ Portfolio – June 2021 Report
Go to Top